Objects
Solowij, Nadia, Galettis, Peter, Broyd, Samantha J., de Krey, Peter, Martin, Jennifer H.. ADIS International; 2018. Second-hand exposure of staff administering vaporised cannabinoid products to patients in a hospital setting.
Lucas, Catherine J., Galettis, Peter, Schneider, Jennifer. Wiley-Blackwell; 2018. The pharmacokinetics and the pharmacodynamics of cannabinoids.
Teng, Christina, Reuter, Stephanie E., Blinman, Prunella L., Dhillon, Haryana M., Galettis, Peter, Proschogo, Nicholas, McLachlan, Andrew J., Vardy, Janette L.. Springer; 2020. Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.
Majimbi, Maimuna, Brook, Emily, Galettis, Peter, Eden, Edward, Al-Salami, Hani, Mooranian, Armin, Al-Sallami, Hesham, Lam, Virginie, Mamo, John C. L., Takechi, Ryusuke. Public Library of Science; 2021. Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid.
Beale, Camilla, Broyd, Samantha J., Chye, Yann, Suo, Chao, Schira, Mark, Galettis, Peter, Martin, Jennifer H., Yücel, Murat, Solowij, Nadia. Mary Ann Liebert; 2018. Prolonged cannabidiol treatment effects on hippocampal subfield volumes in current cannabis users.
Harris, Benjamin D. W., Phan, Viet, Perera, Vidya, Szyc, Anneliese, Galettis, Peter, Martin, Jennifer H., Walpole, Euan, McLachlan, Andrew J., Clarke, Stephen J., Reuter, Stephanie E., Charles, Kellie A.. Adis International; 2020. Inability of current dosing to achieve carboplatin therapeutic targets in people with advanced non-small cell lung cancer: impact of systemic inflammation on carboplatin exposure and clinical outcomes.
Galettis, Peter, Williams, Michelle, Gordon, Rebecca, Martin, Jennifer H.. Commonwealth Scientific and Industrial Research Organisation (CSIRO); 2021. A simple isocratic HPLC method for the quantitation of 17 cannabinoids.
Campbell, Erin J., Bonomo, Yvonne, Pastor, Adam, Collins, Lisa, Norman, Amanda, Galettis, Peter, Johnstone, Janice, Lawrence, Andrew J.. John Wiley & Sons; 2021. The 5-HT<sub>2C</sub> receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment-seeking individuals..
Radovanovic, Mirjana, Jones, Graham, Day, Richard O., Galettis, Peter, Norris, Ross L. G.. Elsevier; 2022. Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry.
Martin, Jennifer H., Schneider, Jennifer, Lucas, Catherine J., Galettis, Peter. Adis International; 2018. Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction?.
Bonomo, Yvonne, Norman, Amanda, Collins, Lisa, O’Neill, Helen, Galettis, Peter, Trinca, Jane, Strauss, Nigel, Martin, Jennifer, Castle, David. Adis International; 2022. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.
Williams, Michelle, Martin, Jennifer, Galettis, Peter. Oxford University Press; 2017. A validated method for the detection of 32 bath salts in oral fluid.
Goulooze, Sebastiaan C., Galettis, Peter, Boddy, Alan V., Martin, Jennifer H.. Springer; 2016. Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumours.
Dryburgh, Laura M., Bolan, Nanthi S., Grof, Christopher P. L., Galettis, Peter, Schneider, Jennifer, Lucas, Catherine J., Martin, Jennifer H.. Wiley-Blackwell; 2018. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects..
Milliken, Eliza, Galettis, Peter, Martin, Jenny. C S I R O Publishing; 2023. A review of psilocybin: chemistry, clinical uses and future research directions.
Radovanovic, Mirjana, Schneider, Jennifer J., Shafiei, Mohsen, Martin, Jennifer H., Galettis, Peter. Elsevier; 2022. Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS.
Williams, Michelle, Martin, Jennifer, Galettis, Peter. Oxford University Press; 2019. A validated method for the detection of synthetic cannabinoids in oral fluid.
Menz, Bradley D., Stocker, Sophie L., Verougstraete, Nick, Kocic, Danijela, Galettis, Peter, Stove, Christophe P., Reuter, Stephanie E.. Wiley-Blackwell; 2021. Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology.
Solowij, Nadia, Broyd, Samantha J., Croft, Rodney J., Martin, Jennifer H., Yücel, Murat, Beale, Camilla, Prick, Julie-Anne, Greenwood, Lisa-Marie, van Hell, Hendrika, Suo, Chao, Galettis, Peter, Pai, Nagesh, Fu, Shanlin. Mary Ann Liebert; 2018. Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular cannabis users: a pragmatic open-label clinical trial.
Hurley, Ellen N., Ellaway, Carolyn J., Johnson, Alexandra M., Truong, Linda, Gordon, Rebecca, Galettis, Peter, Martin, Jennifer H., Lawson, John A.. Wiley-Blackwell; 2022. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial.
O'Hara, Kate, Schneider, Jennifer J., Jones, Alison L., Wright, Ian M. R., Martin, Jennifer H., Galettis, Peter. Taylor & Francis; 2019. Development of an UHPLC-MS/MS method for remifentanil quantification in a small plasma volume.
Liu, Zheng, Galettis, Peter, Broyd, Samantha J., van Hell, Hendrika, Greenwood, Lisa-Marie, de Krey, Peter, Steigler, Amy, Zhu, Xiao, Schneider, Jennifer, Solowij, Nadia, Martin, Jennifer H.. Wiley-Blackwell; 2020. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Shafiei, Mohsen, Mahmood, Alina, Beale, Philip, Galettis, Peter, Martin, Jennifer, McLachlan, Andrew J., Blinman, Prunella. Lippincott Williams & Wilkins; 2023. Dried Blood Spot Sampling in the Monitoring of Anticancer Therapy for Solid Tumors: A Systematic Review.
Radovanovic, Mirjana, Day, Richard O., Jones, Graham D. R., Galettis, Peter, Norris, Ross L. G.. Elsevier; 2022. LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring.
Solowij, Nadia, Broyd, Samantha, Murray, Robin, Jones, Alison, Michie, Patricia T., Croft, Rodney, Greenwood, Lisa-Marie, van Hell, Hendrika, Martelozzo, Dave, Rueb, Kuna, Todd, Juanita, Liu, Zheng, Galettis, Peter, Martin, Jennifer. Springer; 2019. A randomised controlled trial of vaporised Δ⁹-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Schneider, Jennifer J., Galettis, Peter, Martin, Jennifer H.. Wiley-Blackwell; 2021. Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine.
Radovanovic, Mirjana, Galettis, Peter, Flynn, Alex, Martin, Jennifer H., Schneider, Jennifer J.. MDPI AG; 2024. Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice.
Tong, Ziqiu, Esser, Lars, Voelcker, Nicolas H., Galettis, Peter, Rudd, David, Easton, Christopher D., Nilghaz, Azadeh, Peng, Bo, Zhu, Douer, Thissen, Helmut, Martin, Jennifer H.. MDPI AG; 2023. Fluoropolymer Functionalization of Organ-on-Chip Platform Increases Detection Sensitivity for Cannabinoids.
Shafiei, Mohsen, Galettis, Peter, Beale, Philip, Martin, Jennifer H., McLachlan, Andrew J., Blinman, Prunella. Oxford University Press; 2024. Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study.
Shortt, Jake, Galettis, Peter, Cheah, Chan Y., Davis, Joanne, Ludford-Menting, Mandy, Link, Emma K, Martin, Jennifer H., Koldej, Rachel, Ritchie, David. BioMed Central (BMC); 2023. A Phase 1 Clinical Trial of the Repurposable Acetyllysine Mimetic, n-methyl-2-pyrrolidone (NMP), in Relapsed or Refractory Multiple Myeloma.